Today: 1 July 2026
Browse Category

XRP 7 January 2026 - 14 January 2026

XRP price today edges higher on Ripple’s Luxembourg nod as U.S. crypto rules move forward

XRP price today edges higher on Ripple’s Luxembourg nod as U.S. crypto rules move forward

New York, January 14, 2026, 14:00 EST — Regular session XRP ticked up Wednesday after Ripple announced it had secured preliminary approval for an Electronic Money Institution licence in Luxembourg. The token last traded 1.1% higher at $2.13, having ranged between $2.10 and $2.19 in the previous 24 hours. Bitcoin and ether also saw gains, according to CoinMarketCap. Ripple President Monica Long highlighted that Europe’s regulatory framework provides financial firms “the certainty” needed to shift blockchain projects beyond pilot phases to full commercial rollout. Meanwhile, Europe chief Cassie Craddock described Luxembourg as a “premier hub for financial innovation.”
14 January 2026
·
XRP price slips after WisdomTree pulls SEC filing — and Friday’s jobs report looms

XRP price slips after WisdomTree pulls SEC filing — and Friday’s jobs report looms

NEW YORK, Jan 8, 2026, 14:34 EST — Regular session XRP fell on Thursday after WisdomTree asked U.S. regulators to pull its registration for a proposed XRP fund, a filing that traders read as a small but real check on the rush to wrap crypto in stock-market products. XRP was down about 1.8% at $2.14, after trading as low as $2.07 and as high as $2.19. SEC
8 January 2026
····
XRP Price Slips After WisdomTree Pulls XRP ETF Filing as Traders Eye U.S. Jobs Data

XRP Price Slips After WisdomTree Pulls XRP ETF Filing as Traders Eye U.S. Jobs Data

New York, January 7, 2026, 14:36 ET — Regular session XRP fell about 2.2% to $2.19 on Wednesday after WisdomTree asked U.S. regulators to withdraw its proposed spot XRP exchange-traded fund, a filing showed. The sponsor said it had decided “not to proceed at this time” and that no shares were sold under the registration statement, first filed on Dec. 2, 2024. XRP traded between $2.17 and $2.32 in the session. SEC
7 January 2026
····
XRP price today: WisdomTree drops XRP ETF plan as token slides, payrolls in focus

XRP price today: WisdomTree drops XRP ETF plan as token slides, payrolls in focus

New York, Jan 7, 2026, 13:49 EST — Regular session XRP fell on Wednesday after the sponsor of the proposed WisdomTree XRP Fund asked the U.S. Securities and Exchange Commission to withdraw its registration statement, saying it had decided not to proceed “at this time” and that no shares had been sold. The token was down about 2.2% at $2.19 by 1:49 p.m. EST, after touching $2.32 earlier in the day. SEC
7 January 2026
···
1 … 5 6 7 8 9 … 14

Stock Market Today

  • Kymera Therapeutics (KYMR) up 51% YTD as atopic dermatitis drug hits milestones
    July 1, 2026, 2:57 PM EDT. Kymera Therapeutics (KYMR) is up nearly 51% this year, way ahead of the sector's 6.4%. The stock's gain is tied to progress on KT-621, an oral STAT6 degrader for atopic dermatitis and asthma. Kymera wrapped phase IIb enrollment in the BROADEN2 AD trial six months early, aiming to have the pivotal readout by late 2026. Earlier, phase Ib data showed strong STAT6 knockdown and safety. The FDA put KT-621 on Fast Track for moderate-to-severe AD and eosinophilic asthma. Separately, trials for KT-485, in partnership with Sanofi, led to a $20 million milestone, and Kymera is still developing KT-579. Its alliances with Sanofi and Gilead are part of the company's long-term plans.
Go toTop